FreeGulliver LLC’s Neuronetics STIM Stock Holding History

FreeGulliver LLC’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$6.9K	–	131
2025 Q4	$6.9K	Buy	+5,000	New	+$10.5K	﹤0.01%	105

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FreeGulliver LLC's STIM Position: Q1 2026 in Review

FreeGulliver LLC sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 5,000 shares — an estimated $6.9K sold.

FreeGulliver LLC first reported a position in STIM in Q4 2025 and held it in 1 quarter. The position peaked at $6.9K in Q4 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

FreeGulliver LLC reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
FreeGulliver LLC sold 5,000 Neuronetics shares in Q1 2026, an estimated $6.9K.
FreeGulliver LLC first reported a position in Neuronetics in Q4 2025 and held it in 1 quarter.
FreeGulliver LLC's Neuronetics position peaked at $6.9K in Q4 2025.
99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on FreeGulliver LLC's 13F filing for Q1 2026, filed 15 May 2026.